Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC Measure Title Measure Source Radiology: Exposure Time Reported for Procedures Using Fluoroscopy AMA-PCPI/NCQA Oncology: Medical and Radiation – Pain Quantified AMA-PCPI Radiology: Inappropriate Use of “Probably Benign” Assessment Category in Mammography Screening AMA-PCPI Coronary Artery Disease (CAD): Lipid Profile in Patients with CAD AMA-PCPI Chronic Kidney Disease (CKD): Referral for Arteriovenous (AV) Fistula AMA-PCPI Falls: Plan of Care AMA-PCPI Falls: Risk Assessment AMA-PCPI Oncology: Radiation Dose Limits to Normal Tissues AMA-PCPI Hepatitis C: Hepatitis A Vaccination Hepatitis C: Hepatitis B Vaccination Oncology: Recording of Clinical Stage for Lung Cancer and Esophageal Cancer AMA-PCPI AMA-PCPI The following proposed measures are not included in the final 2009 PQRI quality measure set because they were reviewed by NQF on or before August 31, 2008 and were not recommended for endorsement: ● Measure T144 Radiology: Computed Tomography (CT) Radiation Dose Reduction ● Osteoporosis: Counseling for Vitamin D, Calcium Intake, and Exercise Besides being adopted by the AQA, the measures we finalized were considered ready for implementation for the purposes of the 2009 PQRI as of October 15, 2008 based on the following -- (1) the final, detailed specifications for use in data collection for PQRI have been completed and are ready for implementation, and (2) all of the CPT II codes STS 636
CMS-1403-FC required for the measure to be reported by claims have been established and will be effective for CMS claims data submission on or before January 1, 2009. As described in section III.O.4.b, measures designated as T### in the proposed rule indicated that the measure was included in the 2008 Measure Testing Process. The T#### identifier was removed from Table 17 in the final rule with comment period because each measure in the final 2009 PQRI measure set will be assigned an unique number which may be obtained from the detailed specifications which will be made available on the PQRI section of the CMS Web site no later than December 31, 2008. iv. Additional Measures Selected Contingent upon NQF Endorsement or AQA Adoption by August 31, 2008 We proposed to include in the 2009 PQRI quality measure set 26 new measures that had not yet received NQF endorsement or AQA adoption at the time of the publication of the proposed rule but whose selection was contingent on NQF endorsement and/or AQA adoption by August 31, 2008 (73 FR 38571 through 38572). We received several comments on these 26 proposed measures, which are summarized and addressed below. 637
- Page 585 and 586: CMS-1403-FC Comment: We received ma
- Page 587 and 588: CMS-1403-FC Comment: One commenter
- Page 589 and 590: CMS-1403-FC additional 2.0 percent
- Page 591 and 592: CMS-1403-FC EHRs in 2009. The measu
- Page 593 and 594: CMS-1403-FC i. Overview and Summary
- Page 595 and 596: CMS-1403-FC voluntary consensus sta
- Page 597 and 598: CMS-1403-FC Comment: Several commen
- Page 599 and 600: CMS-1403-FC the AMA-PCPI should be
- Page 601 and 602: CMS-1403-FC are appropriate and do
- Page 603 and 604: CMS-1403-FC to make any changes to
- Page 605 and 606: CMS-1403-FC post the measures for p
- Page 607 and 608: CMS-1403-FC beneficiaries. We now h
- Page 609 and 610: CMS-1403-FC identified in Tables 15
- Page 611 and 612: CMS-1403-FC important difference in
- Page 613 and 614: CMS-1403-FC not use Measures #73 Ca
- Page 615 and 616: CMS-1403-FC measures, but which are
- Page 617 and 618: CMS-1403-FC with comment period. Ho
- Page 619 and 620: CMS-1403-FC ● Measure #41 Osteopo
- Page 621 and 622: CMS-1403-FC professional to simply
- Page 623 and 624: CMS-1403-FC measures. We consider t
- Page 625 and 626: CMS-1403-FC Measure Number and Titl
- Page 627 and 628: CMS-1403-FC Measure Number and Titl
- Page 629 and 630: CMS-1403-FC ● Measure #120 CKD: A
- Page 631 and 632: CMS-1403-FC For the 2009 PQRI quali
- Page 633 and 634: CMS-1403-FC rule indicated that the
- Page 635: CMS-1403-FC Response: As suggested
- Page 639 and 640: CMS-1403-FC ● Achievement of NQF
- Page 641 and 642: CMS-1403-FC These additional measur
- Page 643 and 644: CMS-1403-FC We did not include this
- Page 645 and 646: CMS-1403-FC Comment: Many commenter
- Page 647 and 648: CMS-1403-FC groups must have a part
- Page 649 and 650: CMS-1403-FC selected for inclusion
- Page 651 and 652: CMS-1403-FC Measure Title Measure S
- Page 653 and 654: CMS-1403-FC proposed HIV/AIDS measu
- Page 655 and 656: CMS-1403-FC set of denominator spec
- Page 657 and 658: CMS-1403-FC results, for this purpo
- Page 659 and 660: CMS-1403-FC informed decision-makin
- Page 661 and 662: CMS-1403-FC Comment: Several commen
- Page 663 and 664: CMS-1403-FC prior commitments that
- Page 665 and 666: CMS-1403-FC groups who successfully
- Page 667 and 668: CMS-1403-FC ● Eligible profession
- Page 669 and 670: CMS-1403-FC patients, families, and
- Page 671 and 672: CMS-1403-FC that have satisfactoril
- Page 673 and 674: CMS-1403-FC e-prescribing quality m
- Page 675 and 676: CMS-1403-FC Douglas S. and Friedman
- Page 677 and 678: CMS-1403-FC subsequent year, if the
- Page 679 and 680: CMS-1403-FC eligible professional f
- Page 681 and 682: CMS-1403-FC and is included in the
- Page 683 and 684: CMS-1403-FC The measure becomes app
- Page 685 and 686: CMS-1403-FC is, Measure #125) appli
<strong>CMS</strong>-1403-FC<br />
Measure Title Measure Source<br />
Radiology: Exposure Time Reported for Procedures Using Fluoroscopy AMA-PCPI/NCQA<br />
Oncology: Medical and Radiation – Pain Quantified AMA-PCPI<br />
Radiology: Inappropriate Use of “Probably Benign” Assessment Category<br />
in Mammography Screening<br />
AMA-PCPI<br />
Coronary Artery Disease (CAD): Lipid Profile in Patients with CAD AMA-PCPI<br />
Chronic Kidney Disease (CKD): Referral for Arteriovenous (AV) Fistula AMA-PCPI<br />
Falls: Plan of Care AMA-PCPI<br />
Falls: Risk Assessment AMA-PCPI<br />
Oncology: Radiation Dose Limits to Normal Tissues AMA-PCPI<br />
Hepatitis C: Hepatitis A Vaccination<br />
Hepatitis C: Hepatitis B Vaccination<br />
Oncology: Recording of Clinical Stage for Lung Cancer and Esophageal<br />
Cancer<br />
AMA-PCPI<br />
AMA-PCPI<br />
The following proposed measures are not included in<br />
the final 2009 PQRI quality measure set because they were<br />
reviewed by NQF on or before August 31, 2008 and were not<br />
recommended for endorsement:<br />
● Measure T144 Radiology: Computed Tomography (CT)<br />
Radiation Dose Reduction<br />
● Osteoporosis: Counseling for Vitamin D, Calcium<br />
Intake, and Exercise<br />
Besides being adopted by the AQA, the measures we<br />
finalized were considered ready for implementation for the<br />
purposes of the 2009 PQRI as of October 15, 2008 based on<br />
the following -- (1) the final, detailed specifications for<br />
use in data collection for PQRI have <strong>been</strong> completed and are<br />
ready for implementation, and (2) all of the CPT II codes<br />
STS<br />
636